Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
502-04-004 ISMRM Abstract

Integrative Synthetic, Diffusion, and Perfusion MRI for Noninvasive Prediction of Breast Cancer Immunohistochemical Markers

Primary: Body - Breast
Secondary: Contrast Mechanisms - Relaxometry
502-04-004 · New Developments in Breast MRI · Wednesday, 13 May, 4:00 PM–5:50 PM · Hall 1B
Keywords: Breast cancer SyMRI DISCO ADC IHC-Markers
Accepted
Lihua Xiang 1, Jie Shi2, Ling Yang3, Guangzheng Li1
1Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China
2MR Research, Beijing, China
3The Fourth Affiliated Hospital of Soochow University, suzhou, China
Presenting Author: Lihua Xiang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 【1】 Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, Parkin DM, Soerjomataram I, Bray F. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025 Apr 1;156(7):1336-1346. doi: 10.1002/ijc.35278. Epub 2024 Dec 17. PMID: 39688499. [doi] [pmid]
2. 【2】 Królewska-Daszczyńska P, Englisz A, Morawiec ML, Miśkiewicz J, Gołębski M, Mielczarek-Palacz A. The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis. J Cancer Res Clin Oncol. 2025 Aug 22;151(8):233. doi: 10.1007/s00432-025-06271-1. PMID: 40844552; PMCID: PMC12373631. [doi] [pmid]
3. 【3】 Li QY, Liang Y, Zhang L, Li JH, Wang BJ, Wang CF. MRI-based habitat analysis for Intratumoral heterogeneity quantification combined with deep learning for HER2 status prediction in breast cancer. Magn Reson Imaging. 2025 Oct;122:110429. doi: 10.1016/j.mri.2025.110429. Epub 2025 May 23. PMID: 40414575. [doi] [pmid]
4. 【4】 Ziada K, Siu M, Gatt R, Jallad N, Hartley N, McDonald G, Al-Attar M. High-risk breast cancer screening with MRI: diagnostic performance of a local scoring system. Clin Radiol. 2025 Aug;87:106968. doi: 10.1016/j.crad.2025.106968. Epub 2025 May 22. PMID: 40554189. [doi] [pmid]
5. 【5】 Pires T, Pendem S, M M J, Priyanka. Technical aspects and clinical applications of synthetic MRI: a scoping review. Diagnosis (Berl). 2025 Feb 7. doi: 10.1515/dx-2024-0168. Epub ahead of print. PMID: 39913860. [doi] [pmid]
6. 【6】 Morrison CK, Henze Bancroft LC, DeMartini WB, Holmes JH, Wang K, Bosca RJ, Korosec FR, Strigel RM. Novel High Spatiotemporal Resolution Versus Standard-of-Care Dynamic Contrast-Enhanced Breast MRI: Comparison of Image Quality. Invest Radiol. 2017 Apr;52(4):198-205. doi: 10.1097/RLI.0000000000000329. PMID: 27898602; PMCID: PMC5339074. [doi] [pmid]
7. 【7】 Kim H, Chi SA, Kim K, Han BK, Ko EY, Choi JS, Lee J, Kim MK, Ko ES. Ultrafast sequence-based prediction model and nomogram to differentiate additional suspicious lesions on preoperative breast MRI. Eur Radiol. 2025 Jan;35(1):188-201. doi: 10.1007/s00330-024-10931-0. Epub 2024 Jul 17. PMID: 39014088. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/502-04-004